# Samchundang Pharm Co., Ltd., Hwaseong, Korea (the Republic of) – FDA Inspections

Source: https://www.keypedia.com/companies/samchundang-pharm-co-ltd/953048a3-14c3-475b-bebc-f43b8755905e

> Inspection records and compliance data for Samchundang Pharm Co., Ltd. in Hwaseong. 3 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected October 27, 2022.

---

## Details

- Name: Samchundang Pharm Co., Ltd.
- FEI Number: 3008425092
- Address Line 1: Hyangnam Pharmaceutical Industries Complex, 71 Jeyakgongdan2-Gil; Hyangnam-Eup
- City: Hwaseong
- Country Name: Korea (the Republic of)
- Address: Hyangnam Pharmaceutical Industries Complex, 71 Jeyakgongdan2-Gil; Hyangnam-Eup, Hwaseong, Korea (the Republic of)
- Country: Korea (the Republic of)

## Related Documents

- [483 - Samchundang Pharm Co., Ltd. - 2026-05-19](https://www.keypedia.com/records/483/samchundang-pharm-co-ltd/63bbbe31-dec6-4b57-bff2-47c7668f7df9) — source: FDA, date: May 19, 2026
- [FDA Inspection 1182341 - Samchundang Pharm Co., Ltd. - 2022-10-27](https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/fe953692-aab1-43f0-8f63-2b7e23800df8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2022
- 483 - Samchundang Pharm Co., Ltd. - 2019-10-25 — source: FDA, date: October 25, 2019
- [WARNING_LETTER - Samchundang Pharm Co., Ltd. - 2019-10-25](https://www.keypedia.com/records/warning_letter/samchundang-pharm-co-ltd/feb7da80-5052-406c-8658-c15e62f36fba) — source: FDA, date: October 25, 2019
- [FDA Inspection 1107697 - Samchundang Pharm Co., Ltd. - 2019-10-25](https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/714d4b85-4365-4913-981e-ad2f5b4379ec) — classification: Official Action Indicated (OAI), source: FDA, date: October 25, 2019
- [FDA Inspection 1024442 - Samchundang Pharm Co., Ltd. - 2017-09-08](https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/8e5c98f3-abb1-45a7-928d-8666e8f66aa0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2017

## Related Companies

- [IDO PHARM](https://www.keypedia.com/companies/ido-pharm/f9c98a5c-4dc5-424d-98ab-461778ae3ea9)
- [Natuzen Co.,Ltd.](https://www.keypedia.com/companies/natuzen-coltd/28321a1a-7dc5-4f25-94d8-dbaca00bf3ea)
- [Intercos Europe S.p.A](https://www.keypedia.com/companies/intercos-europe-spa/d0e271a6-ff7f-494e-a45b-ef3994a32e5a)
- [AbbVie Ireland NL. B.V.](https://www.keypedia.com/companies/abbvie-ireland-nl-bv/d26b61d9-4a9b-4352-9400-043b23ba5d10)
- [Midwest Medical Isotopes LLC](https://www.keypedia.com/companies/midwest-medical-isotopes-llc/1e9aacf6-98ec-4c57-aff8-7c8fff206f43)
- [AQ USA, INC.](https://www.keypedia.com/companies/aq-usa-inc/f1584271-9683-4bcc-a227-1361808ce799)
- [Orange Lab Holdings](https://www.keypedia.com/companies/orange-lab-holdings/6e4e0169-84f8-44f1-8f57-0f0886557ff8)
- [CDYMAX (INDIA) PHARMA PRIVATE LIMITED](https://www.keypedia.com/companies/cdymax-india-pharma-private-limited/f1f48359-fb6a-47b2-8d2f-4106b353db6d)
- [Airgas USA LLC](https://www.keypedia.com/companies/airgas-usa-llc/b4ba38db-4a53-461e-954f-0f2273b6d469)
- [Zhejiang Meimi Technology Co., Ltd.](https://www.keypedia.com/companies/zhejiang-meimi-technology-co-ltd/46549fb6-82b4-402e-b2c6-ec5fa6c6dad1)

## Related Officers

- [Philip F. Istafanos](https://www.keypedia.com/people/philip-f-istafanos/c2fcfe52-1070-4551-bffc-f8bcfad5b30b)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)
- [Damaris Y. Hernandez](https://www.keypedia.com/people/damaris-y-hernandez/ca16093e-047b-4bf1-bcc1-c439cff21e8a)